Education
About Us
Working with TipRanks
Follow Us
Arecor Therapeutics PLC (GB:AREC)
LSE:AREC
RESEARCH TOOLSreports
See the Price Targets and Ratings of:
AREC Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
56p
Hold
-0.88%
Downside
Reiterated
07/25/25
Arecor Therapeutics PLC shows potential with strong technical momentum and positive corporate events, but ongoing financial challenges and an unattractive valuation score due to losses and lack of dividends weigh on the overall score. The company's strategic initiatives in R&D and executive confidence are promising, but caution is advised due to high volatility and financial instability typical of biotech firms.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
56p
Hold
-0.88%
Downside
Reiterated
07/25/25
Arecor Therapeutics PLC shows potential with strong technical momentum and positive corporate events, but ongoing financial challenges and an unattractive valuation score due to losses and lack of dividends weigh on the overall score. The company's strategic initiatives in R&D and executive confidence are promising, but caution is advised due to high volatility and financial instability typical of biotech firms.
AREC Analyst Recommendation Trends
Rating
May 25
Jun 25
Jul 25
Strong Buy
0
0
0
Buy
0
0
0
Hold
5
7
13
Sell
0
0
0
Strong Sell
0
0
0
total
5
7
13
Each month's total comprises the sum of three months' worth of ratings.
AREC Stock Forecast FAQ
What is GB:AREC’s average 12-month price target, according to analysts?
Based on analyst ratings, Arecor Therapeutics PLC’s 12-month average price target is 45.00.
What is GB:AREC’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for GB:AREC, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Arecor Therapeutics PLC a Buy, Sell or Hold?
Arecor Therapeutics PLC has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Arecor Therapeutics PLC’s share price target?
The average share price target for Arecor Therapeutics PLC is 45.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is 45.00p ,and the lowest forecast is 45.00p. The average share price target represents -20.35% Decrease from the current price of 56.5p.
The highest analyst share price target is 45.00p ,and the lowest forecast is 45.00p. The average share price target represents -20.35% Decrease from the current price of 56.5p.
What do analysts say about Arecor Therapeutics PLC?
Arecor Therapeutics PLC’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of Arecor Therapeutics PLC?
To buy shares of GB:AREC, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.